Jafron Biomedical Co.,Ltd. (SHE:300529)
China · Delayed Price · Currency is CNY 19.79
-0.25 (-1.25%)
At close: Feb 13, 2026
Jafron Biomedical Market Cap
Jafron Biomedical has a market cap or net worth of 15.32 billion as of February 13, 2026. Its market cap has decreased by -33.25% in one year.
Market Cap
15.32B
Enterprise Value
14.27B
Revenue
2.04B
Ranking
n/a
PE Ratio
31.44
Stock Price
19.79
Market Cap Chart
Since August 2, 2016, Jafron Biomedical's market cap has increased from 6.41B to 15.32B, an increase of 139.20%. That is a compound annual growth rate of 9.57%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 13, 2026 | 15.32B | 0.61% |
| Dec 31, 2025 | 15.23B | -32.96% |
| Dec 31, 2024 | 22.72B | 27.96% |
| Dec 29, 2023 | 17.76B | -28.23% |
| Dec 30, 2022 | 24.74B | -42.00% |
| Dec 31, 2021 | 42.65B | -21.30% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Aug 2, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Autobio Diagnostics | 20.93B |
| Double Medical Technology | 19.46B |
| MeHow Innovative | 17.98B |
| Shandong Weigao Blood Purification Products | 16.92B |
| Beijing Balance Medical Technology | 14.21B |
| Shanghai MicroPort Endovascular MedTech | 11.95B |
| Shandong Weigao Orthopaedic Device | 11.85B |
| SonoScape Medical | 11.52B |